New evidence confirmed that the repressive effects of the cornerstone of treatment for asthma, glucocorticoids, linked to the inflammatory pathways and genes and PDK4 can regulate glucose metabolism to explain the metabolic effects of glucocorticoids [31]. The gene discussed is PDK4; the disease is asthma.